bbic-bridge-logo

B-BIC News and Events:
What's Happening

Specialist Series: Filling the Unmet Need – Your Proposed Solution

By B-BIC | December 11, 2017

Contributed by Ron Blackman In our previous newsletter, we described how to identify the unmet need that will be served by your device or therapeutic, and here we will help you build the case that you have a solution to meet that need.  A number of points should be addressed and we will go through…

Read More

Tips & Tricks: Defining Your Need Statement

By B-BIC | November 10, 2017

Contributed by Josh Tolkoff An unmet need is more than an incremental improvement and once it exists in the market – it makes a substantial change for the better. Talk with many stakeholders (patients, clinicians, hospital administrators, hospital purchasing agents, insurance providers, etc.) to better understand the need, and determine what kind of solutions would…

Read More

Specialist Series: Finding and Defining Your Unmet Need

By B-BIC | November 10, 2017

Contributed by Josh Tolkoff The most common reason for the commercial failure of a start-up entity is not having a compelling clinical need.  What exactly is an “unmet need”?  An unmet need is something more than an incremental improvement, and once it exists in the market it will make a substantial change for the better.…

Read More

NEW AWARD: CONGRATULATIONS, DR. SYLVIE BRETON!

By B-BIC | November 10, 2017

RECIPIENT:  Dr. Sylvie Breton TITLE: Predicting and Preventing Acute Kidney Injury Associated with Cardiovascular Diseases TYPE OF AWARD:  PILOT TECHNOLOGY TYPE: Small Molecule Drug CLINICAL AREA: Heart INDICATION: Acute Kidney Injury INSTITUTION: MGH DESCRIPTION:  Acute kidney injury (AKI) is a frequent complication of hospitalized patients. Unfortunately, there is no cure for this potentially deadly condition. Thus, a critical…

Read More

NEW AWARD: CONGRATULATIONS DR. NELSON RUIZ – OPAZO

By B-BIC | October 30, 2017

RECIPIENT:  Dr. Nelson Ruiz – Opazo TITLE: Fully humanized anti-DEpR antibody therapy for acute lung injury (ALI)/Acute Respiratory Distress Syndrome (ARDS) TYPE OF AWARD:  PILOT TECHNOLOGY TYPE: Biologic Drug CLINICAL AREA: Lung INDICATION: Acute Lung Injury / Acute Respiratory Distress Syndrome INSTITUTION: Boston University DESCRIPTION:The feed-forward progression of acute lung injury (ALI) towards acute respiratory distress syndrome (ARDS)…

Read More

Tips & Tricks:  Writing your B-BIC Proposal or Business Plan Overview

By B-BIC | October 30, 2017

The best way to begin an overview is by presenting a clear picture of the problem that needs to be solved.  Aim to tell a narrative story about the specific problem that patients or clinicians are currently experiencing. Address a specific disease or healthcare management issue, and include key facts to show the potential market size. Define…

Read More

Specialist Series: How to build an effective overview of your technology.

By B-BIC | October 30, 2017

Contributed by Erin McKenna, B-BIC Deputy Director After the dip in investment in early-stage biotechnology in 2008, the number of funding opportunities for early-stage technologies has been increasing in recent years. Despite this promising trend, finding and securing the funding necessary to move your research out of the lab and towards commercialization is still a…

Read More

NIH Centers for Accelerated Innovations Program: principles, practices, successes and challenges

By B-BIC | September 25, 2017

Commercializing innovations in academic environments is notoriously challenging. Here, we describe the progress of the NIH Centers for Accelerated Innovations program — initiated in 2013 to address these challenges — which we believe could help set a new standard for the early-stage commercialization of biomedical innovations in academic environments. Read More On Nature.com.

Read More

Specialist Series: Reimbursement

By B-BIC | September 11, 2017

If reimbursement is so important … why do so many companies address it so half-heartedly and so late? Edward E. Berger, Ph.D. Everyone knows how important reimbursement analysis and planning is to the success of innovative medical technology and life science products.  Ask any venture capitalist, private equity investor, strategic marketing analyst, or C-level executive;…

Read More

NEW AWARD: CONGRATULATIONS DR. LEO TSAI!

By B-BIC | September 5, 2017

RECIPIENT: Dr. Leo Tsai TITLE: A Novel Coaxial Deflectable Microcatheter for Rapid Navigation of Tortuous Vessels TYPE OF AWARD: DRIVE INSTITUTION: Beth Israel Deaconess Medical Center TECHNOLOGY TYPE: Therapeutic Device DESCRIPTION: Microcatheters are used to access small vessels throughout the body to treat a wide variety of pathology, from traumatic hemorrhage to tumors. Selection of…

Read More